← Eichor
Study identifier: NCT06223828 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Azithromycin for Critical Asthma - Pediatrics

Condition: Pediatric Asthma · Critical Illness  ·  Sponsor: Johns Hopkins All Children's Hospital

PhasePhase 2/Phase 3
Planned participants100
Who can joinAll sexes, 3 Years to 17 Years
Healthy volunteersNo

About this study

The CR-AZI Study will assess the immunomodulatory effects of Azithromycin for pediatric Critical Asthma.

This description comes directly from the study's public registry record.

Talk to the study team

Anthony A Sochet, MD  ·  727-487-3711  ·  Sochet@jhmi.edu

Alexa R Roberts, MD  ·  602-526-4397  ·  arober77@jhmi.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Johns Hopkins All Children's HospitalSt. Petersburg, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06223828